The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ISHARES CORE S AND P 500 ETF | CORE S&P500 ETF | 464287200 | 128,166 | 478,150 | SH | SOLE | 0 | 0 | 478,150 | ||
ALPHABET INC-CL C | COM | 02079K107 | 2,123 | 2,197 | SH | SOLE | 2,197 | 0 | 0 | ||
VANGUARD FTSE ALL-WORLD EX-U | ALLWRLD EX US | 922042775 | 483 | 8,625 | SH | SOLE | 0 | 0 | 8,625 | ||
VANGUARD FTSE DEVELOPED ETF | FTSE DEV MKT ETF | 921943858 | 442 | 9,500 | SH | SOLE | 0 | 0 | 9,500 | ||
VANGUARD MSCI EMERGING MARKE | FTSE EMR MKT ETF | 922042858 | 408 | 9,100 | SH | SOLE | 0 | 0 | 9,100 | ||
VANGUARD FTSE EUROPE ETF | FTSE EUROPE ETF | 922042874 | 330 | 5,250 | SH | SOLE | 0 | 0 | 5,250 | ||
STARBUCKS CORP | COM | 855244109 | 328 | 4,238 | SH | SOLE | 4,238 | 0 | 0 | ||
LOCKHEED MARTIN CORP | COM | 539830109 | 273 | 951 | SH | SOLE | 951 | 0 | 0 | ||
LOWE'S COS INC | COM | 548661107 | 240 | 2,441 | SH | SOLE | 2,441 | 0 | 0 | ||
SPDR S and P DIVIDEND ETF | S&P DIVID ETF | 78464A763 | 207 | 2,000 | SH | SOLE | 0 | 0 | 2,000 | ||
VANGUARD TOTAL STOCK MKT ETF | VANGUARD INDEX FDS | 922908769 | 204 | 1,500 | SH | SOLE | 0 | 0 | 1,500 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 146 | 16,075 | SH | SOLE | 16,075 | 0 | 0 |